Park, I., Mundy-Bosse, B., Whitman, S., Zhang, X., Warner, S., Bearss, D., . . . Caligiuri, M. (2015). Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia. Leukemia.

Park, I-K, B. Mundy-Bosse, SP Whitman, X. Zhang, SL Warner, DJ Bearss, W. Blum, G. Marcucci, and MA Caligiuri. "Receptor Tyrosine Kinase Axl Is Required for Resistance of Leukemic Cells to FLT3-targeted Therapy in Acute Myeloid Leukemia." Leukemia 2015.

Park, I-K, et al. "Receptor Tyrosine Kinase Axl Is Required for Resistance of Leukemic Cells to FLT3-targeted Therapy in Acute Myeloid Leukemia." Leukemia 2015.